Complement in central nervous system inflammation

被引:62
作者
Barnum, SR [1 ]
机构
[1] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA
关键词
complement; anaphylatoxin receptors; glial cells; neurons; experimental allergic encephalomyelitis; neurobiology;
D O I
10.1385/IR:26:1-3:007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The complement system is well represented in the central nervous system. Glial cells and neurons produce or express all of the activation and regulatory proteins and the C3a/C5a receptors. Inhibition of complement activation is protective in experimental allergic encephalomyelitis, the animal model for multiple sclerosis, suggesting possible therapeutic approaches for human disease. New findings indicate that the C3a/C5a receptors are widely expressed in neurons and may modulate neuronal function.
引用
收藏
页码:7 / 13
页数:7
相关论文
共 40 条
[1]   Inhibition of complement as a therapeutic approach in inflammatory central nervous system (CNS) disease [J].
Barnum, SR .
MOLECULAR MEDICINE, 1999, 5 (09) :569-582
[2]  
BARNUM SR, 2001, INFLAMMATORY EVENTS, P139
[3]  
BOOS L, 2001, J NEUROIMMUNOL, V118, P11
[4]   Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice [J].
Calida, DM ;
Constantinescu, C ;
Purev, E ;
Zhang, GX ;
Ventura, ES ;
Lavi, E ;
Rostami, A .
JOURNAL OF IMMUNOLOGY, 2001, 166 (02) :723-726
[5]   Transgenic models to study the actions of cytokines in the central nervous system [J].
Campbell, IL ;
Stalder, AK ;
Akwa, Y ;
Pagenstecher, A ;
Asensio, VC .
NEUROIMMUNOMODULATION, 1998, 5 (3-4) :126-135
[6]   The role of complement and complement receptors in induction and regulation of immunity [J].
Carroll, MC .
ANNUAL REVIEW OF IMMUNOLOGY, 1998, 16 :545-568
[7]   Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA [J].
Circolo, A ;
Garnier, G ;
Fukuda, W ;
Wang, XF ;
Hidvegi, T ;
Szalai, AJ ;
Briles, DE ;
Volanakis, JE ;
Wetsel, RA ;
Colten, HR .
IMMUNOPHARMACOLOGY, 1999, 42 (1-3) :135-149
[8]  
Davoust N, 1999, J IMMUNOL, V163, P6551
[9]  
Davoust N, 1999, GLIA, V26, P201, DOI 10.1002/(SICI)1098-1136(199905)26:3<201::AID-GLIA2>3.0.CO
[10]  
2-M